Italia markets closed

TEVA Jul 2024 16.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1100-0,0800 (-42,11%)
In data: 03:44PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1900
Aperto0,2000
Denaro0,1000
Domanda0,1700
Prezzo d'esercizio16,50
Scadenza2024-07-05
Min-Max giorno0,1000 - 0,2000
Contratto - Min-MaxN/D
Volume442
Open Interest204
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.